Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
Australian public assessment report (AusPar) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (302)
2016 (34)
2015 (52)
2014 (32)

Search

Sponsor content

1423 result(s) found, displaying 1221 to 1230

APO-Olmesartan olmesartan medoxomil 20mg tablet bottles Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Olmesartan olmesartan medoxomil 40mg tablet bottles Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-OLMESARTAN HCTZ 20/12.5 olmesartan medoxomil 20 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-OLMESARTAN HCTZ 40/12.5 olmesartan medoxomil 40 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-OLMESARTAN HCTZ 40/25 olmesartan medoxomil 40 mg & hydrochlorothiazide 25 mg tablet bottle Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PREGABALIN pregabalin 75 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PREGABALIN pregabalin 100 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PREGABALIN pregabalin 150 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PREGABALIN pregabalin 200 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PREGABALIN pregabalin 225 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd

Pages

First page
Previous page
…
Page 119
Page 120
Page 121
Page 122
Current page 123
Page 124
Page 125
Page 126
Page 127
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.